EirGenix, Inc.’s Post

🌟 Discover EirGenix’s Educational Blog Series! 🌟 Have you explored our latest blog series yet? Dive into insightful articles on topics like optimizing Cell Line Development (CLD), the latest trends in Antibody Drug Conjugates (ADCs), key considerations for developing bispecific mAbs, and mastering both upstream and downstream mAb development. Plus, learn about the crucial aspects of Biologic Technology Transfer and much more! Join our community of biological developers dedicated to continuous learning. If you find our content valuable, please share it and help us in our mission to provide effective, affordable care to patients. Check it out here: EirGenix Blog Series 🚀 #Biotech #Pharma #Healthcare #LearningCommunity #EirGenix #CDMO #CLD #mAb #ADC #CMO

How are the needs of discovery labs evolving and what would label-free technologies need to do to accommodate evolving needs? Join Sriram Kumaraswamy for the discussion at our Antibody Therapeutics Roundtable Xchange happening in #SanDiego, February 26th. To secure your spot, view full agendas and more, please visit https://lnkd.in/eUhXgMbZ Please note: Registration is only open to Senior Scientists and above actively working in the #pharmaceutical / #biotech industry. Each roundtable is limited to 8 participants. #hubXchangeNotAConference #pharma #bigdata #datasciences #lifesciences #drugdevelopment #pharmacology #genomics #advancedtherapies #therapeutics #therapies #antibodytherapeutics #antibodyoptimisation #antibodydiscovery #emergingtechnologies #targetedtherapies

How are the needs of discovery labs evolving and what would label-free technologies need to do to accommodate evolving needs? Join Sriram Kumaraswamy for the discussion at our Antibody Therapeutics Roundtable Xchange happening in #SanDiego, February 26th. To secure your spot, view full agendas and more, please visit https://lnkd.in/ew2y26Yv Please note: Registration is only open to Senior Scientists and above actively working in the #pharmaceutical / #biotech industry. Each roundtable is limited to 8 participants. #hubXchangeNotAConference #pharma #bigdata #datasciences #lifesciences #drugdevelopment #pharmacology #genomics #advancedtherapies #therapeutics #therapies #antibodytherapeutics #antibodyoptimisation #antibodydiscovery #emergingtechnologies #targetedtherapies

How are the needs of discovery labs evolving and what would label-free technologies need to do to accommodate evolving needs? Join Sriram Kumaraswamy for the discussion at our Antibody Therapeutics Roundtable Xchange happening in #SanDiego, February 26th. To secure your spot, view full agendas and more, please visit https://lnkd.in/emDh2T8B Please note: Registration is only open to Senior Scientists and above actively working in the #pharmaceutical / #biotech industry. Each roundtable is limited to 8 participants. #hubXchangeNotAConference #pharma #bigdata #datasciences #lifesciences #drugdevelopment #pharmacology #genomics #advancedtherapies #therapeutics #therapies #antibodytherapeutics #antibodyoptimisation #antibodydiscovery #emergingtechnologies #targetedtherapies

"To select the best lead antibody for clinical use, it’s crucial to have a diverse panel of lead candidates." Join Andra Li, Ph.D. for her presentation at our Antibody Therapeutics Roundtable Xchange happening in #SanDiego, February 26th. To secure your spot, view full agendas and more, please visit https://lnkd.in/emDh2T8B Please note: Registration is only open to Senior Scientists and above actively working in the #pharmaceutical / #biotech industry. Each roundtable is limited to 8 participants. #hubXchangeNotAConference #pharma #bigdata #datasciences #lifesciences #drugdevelopment #pharmacology #genomics #advancedtherapies #therapeutics #therapies #antibodytherapeutics #antibodyoptimisation #antibodydiscovery #emergingtechnologies #targetedtherapies

Join us to explore how Seismic Therapeutic™ applies machine learning to biologics drug discovery to develop therapies to address autoimmune diseases. Learn about rapid, high-throughput screening of drug activity. https://bit.ly/49dhks4 #biotech #drugdevelopment

"To select the best lead antibody for clinical use, it’s crucial to have a diverse panel of lead candidates." Join Andra Li, Ph.D. for her presentation at our Antibody Therapeutics Roundtable Xchange happening in #SanDiego, February 26th. To secure your spot, view full agendas and more, please visit https://lnkd.in/ew2y26Yv Please note: Registration is only open to Senior Scientists and above actively working in the #pharmaceutical / #biotech industry. Each roundtable is limited to 8 participants. #hubXchangeNotAConference #pharma #bigdata #datasciences #lifesciences #drugdevelopment #pharmacology #genomics #advancedtherapies #therapeutics #therapies #antibodytherapeutics #antibodyoptimisation #antibodydiscovery #emergingtechnologies #targetedtherapies

Join us to explore how Seismic Therapeutic™ applies machine learning to biologics drug discovery to develop therapies to address autoimmune diseases. Learn about rapid, high-throughput screening of drug activity. https://bit.ly/49dhks4 #biotech #drugdevelopment

"To select the best lead antibody for clinical use, it’s crucial to have a diverse panel of lead candidates." Join Andra Li, Ph.D. for her presentation at our Antibody Therapeutics Roundtable Xchange happening in #SanDiego, February 26th. To secure your spot, view full agendas and more, please visit https://lnkd.in/eUhXgMbZ Please note: Registration is only open to Senior Scientists and above actively working in the #pharmaceutical / #biotech industry. Each roundtable is limited to 8 participants. #hubXchangeNotAConference #pharma #bigdata #datasciences #lifesciences #drugdevelopment #pharmacology #genomics #advancedtherapies #therapeutics #therapies #antibodytherapeutics #antibodyoptimisation #antibodydiscovery #emergingtechnologies #targetedtherapies

😯Seminar this Thursday😯computer-aided drug design (CADD)😯 🧬Accelerating Antibiotic Drug Design with Computational Approaches💻 In the quest for innovative antibiotic therapies, computational approaches have become invaluable tools for interpreting and guiding experiments. Two primary types of computer-aided drug design (CADD) methods—Structure-Based Drug Design (SBDD) and Ligand-Based Drug Design (LBDD)—are at the forefront of this revolution. 🔍 Structure-Based Drug Design (SBDD): - Utilizes 3D structural information of macromolecular targets, like proteins or RNA. - Identifies key sites and interactions essential for biological functions. - Aims to design drugs that disrupt vital interactions, thwarting microorganism survival. 🔬 Ligand-Based Drug Design (LBDD): - Focuses on known antibiotic ligands and their relationship with physiochemical properties. - Establishes structure-activity relationships (SAR) to optimize existing drugs. - Guides the design of new drugs with enhanced activity. #DrugDiscovery #Antibiotics #CADD #SBDD #LBDD #Pharmaceuticals #Innovation #ComputationalBiology #SAR #PharmaTech #BiomedicalResearch #MolecularModeling #DrugRepurposing #ClinicalTrials